{"nct_id":"NCT06036836","title":"Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-03","start_date":"2023-09-29","start_date_type":"ACTUAL","primary_completion_date":"2027-03-09","primary_completion_date_type":"ESTIMATED","completion_date":"2027-03-09","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}